Clinical studies with tubercidin administered after absorption into human erythrocytes.
D000042:Absorption; D001786:Blood Glucose / Q000032:analysis; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D004492:Edetic Acid / Q000097:blood / Q000627:therapeutic use / Q000633:toxicity; D004912:Erythrocytes / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy; D009705:Nucleosides / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity
D001786:Blood Glucose; D009705:Nucleosides; D004492:Edetic Acid